Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Genprex Inc market cap is $1.94M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genprex Inc 52 week high is $80.96 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genprex Inc 52 week low is $1.45 as of November 22, 2026.
Genprex Inc stock price today is $1.45.
Genprex Inc stock price yesterday was $1.67.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Genprex Inc's P/E ratio is -0.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Genprex Inc P/B ratio is 0.1288.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Genprex Inc 50-day moving average is $2.48.